Venetoclax ex vivo functional profiling predicts improved progression-free survival

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2044-5385
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Venetoclax ex vivo functional profiling predicts improved progression-free survival ; volume:12 ; number:8 ; day:4 ; month:8 ; year:2022 ; pages:1-4 ; date:8.2022
Blood cancer journal ; 12, Heft 8 (4.8.2022), 1-4, 8.2022

Creator
Gupta, Vikas A.
Matulis, Shannon M.
Barwick, Benjamin G.
Bog, R. Devin
Shebelut, Conrad W.
Shanmugam, Mala
Neri, Paola
Bahlis, Nizar J.
Dhodapkar, Madhav V.
Heffner, Leonard T.
Hofmeister, Craig C.
Joseph, Nisha S.
Lonial, Sagar
Kaufman, Jonathan L.
Jaye, David L.
Nooka, Ajay K.
Boise, Lawrence H.
Contributor
SpringerLink (Online service)

DOI
10.1038/s41408-022-00710-9
URN
urn:nbn:de:101:1-2022101920535748855955
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Gupta, Vikas A.
  • Matulis, Shannon M.
  • Barwick, Benjamin G.
  • Bog, R. Devin
  • Shebelut, Conrad W.
  • Shanmugam, Mala
  • Neri, Paola
  • Bahlis, Nizar J.
  • Dhodapkar, Madhav V.
  • Heffner, Leonard T.
  • Hofmeister, Craig C.
  • Joseph, Nisha S.
  • Lonial, Sagar
  • Kaufman, Jonathan L.
  • Jaye, David L.
  • Nooka, Ajay K.
  • Boise, Lawrence H.
  • SpringerLink (Online service)

Other Objects (12)

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma

Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma

Androgen receptor profiling predicts prostate cancer outcome

Androgen receptor profiling predicts prostate cancer outcome

Venetoclax – The Game-changer in Hematology

Venetoclax – The Game-changer in Hematology

Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy

Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy

Progression-free sets and rank of matrices

zweidimensionales bewegtes Bild

Progression-free sets and rank of matrices

Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)

Venetoclax - ein neuer Therapiestandard in der AML

Venetoclax - ein neuer Therapiestandard in der AML

Venetoclax bei der chronischen lymphatischen Leukämie (CLL)

Fallstudiensammlung

Venetoclax bei der chronischen lymphatischen Leukämie (CLL)

Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma

Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma

Related objects